Researchers at Moffitt Cancer Center and colleagues at the University of South Florida have found that when given together, a two-drug combination acts synergistically in test animals modeled with sarcoma tumors. They report that the drug combination of MK-1775 and gemcitabine resulted in a 70 percent decrease in the tumor volume when compared to receiving one drug or the other.
Fuente : http://www.eurekalert.org/pub_releases/2013-04/hlm...
Fuente : http://www.eurekalert.org/pub_releases/2013-04/hlm...